BAT lobby Brazil to push for legalization and regulation of e-cigarettes

Apr.17.2025
 BAT lobby Brazil to push for legalization and regulation of e-cigarettes
BAT Brazil continues lobbying efforts to legalize and regulate e-cigarettes in Brazil, showcasing technological advancements to sway public opinion.

Key Highlights:

Lobbying tactics: British American Tobacco uses methods such as organizing media tours of its research and development factories and showcasing its technological investments to convey to the public and regulators an image of e-cigarettes as being capable of regulation, control, and mature technology.

2. Industry demands are clearly defined: BAT does not advocate for completely lifting the ban on e-cigarettes, but rather aims to promote a controlled, regulated, and registered legal market to combat black market products.

Government regulatory shift signs: Despite Anvisa previously maintaining a ban, regulators' language has shifted from "absolute prohibition" to "seriously considering" the information provided by the industry, showing a softening attitude.

Legislative support: BAT explicitly supports the bill proposed by Senator (PL 5008/2023), showing that they are not only lobbying from an administrative perspective, but also pushing for legalization through the legislative process.

Industry impact estimation: Once the bill is passed, Brazil may become the first major country in Latin America to open up the e-cigarette market, providing international companies with a new market that is regulated and can be anticipated.


According to a report by Metro1 on April 10th, despite the Brazilian National Health Surveillance Agency (Anvisa) deciding to uphold the ban on the sale of e-cigarettes in December of last year, British American Tobacco's Brazilian subsidiary (BAT Brasil) has not given up on lobbying efforts. They are now supporting a proposed bill to push for the legalization and regulation of e-cigarettes.

 

In order to strengthen media influence, BAT recently invited 17 journalists from about 15 media outlets to visit its research and development center in Rio Grande do Sul, Brazil. The center focuses on the development of new reduced harm products, with BAT emphasizing the technological content and safety of its products in an attempt to shape a compliant alternative image in the public opinion.

 

The BAT institution affairs manager stated that the company does not advocate for the liberalization of sales, but rather supports comprehensive regulation of the e-cigarette market.

 

The bill supported by BAT (PL 5008/2023) was introduced by Senator Soraya Thronicke from the Podemos-MS party, with the aim of promoting the establishment of a regulatory system for the entire e-cigarette chain in Brazil, from raw material control to product distribution, all within a legal framework. The proposal suggests adopting a regulatory model similar to that of the UK - limiting the sale of traditional cigarettes while encouraging e-cigarettes as a smoking cessation tool.

 

Although Anvisa began a public consultation on e-cigarettes last year, receiving over 13,000 feedback responses, its final stance has not yet been made clear. The agency recently released a statement indicating that the issue is currently "undergoing a technical analysis stage, evaluating the scientific evidence received and Brazil's socioeconomic context.

 

This series of actions demonstrates that Brazil's e-cigarette policy is currently in a crucial stage of strategic interaction. The interplay between the industry and regulatory authorities could have a profound impact on the country's future path to harm reduction in tobacco.

 

Main image source: Agência Brasil/Joedson Alves.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Product | Republic Technologies Launches ZIG Nicotine Pouches, Expanding Beyond Traditional Tobacco Accessories
Product | Republic Technologies Launches ZIG Nicotine Pouches, Expanding Beyond Traditional Tobacco Accessories
Republic Technologies UK has entered the nicotine pouch market with ZIG Nicotine Pouches, marking the company’s expansion beyond traditional tobacco-related accessories into smoke-free nicotine products. The product is expected to enter UK retail channels from August 2026, including convenience stores, supermarkets and tobacco retailers. The launch includes six flavors and three nicotine strengths: 8mg, 12mg and 17mg.
Market
Jul.21 by 2Firsts Perspectives
BofA Upgrades Imperial Brands, Says Market Overreacted to Australia Slump
BofA Upgrades Imperial Brands, Says Market Overreacted to Australia Slump
Bank of America upgraded Imperial Brands to “buy” from “neutral,” saying investors have overreacted to the tobacco group’s Australian business downturn and that the share-price pullback has created a more attractive entry point.
Jul.16
China’s HTP Exports Fell 14.3% in H1 2026 as Russia and Belarus Accounted for 76% Lead
China’s HTP Exports Fell 14.3% in H1 2026 as Russia and Belarus Accounted for 76% Lead
In H1 2026, China’s HS 24041100 exports stood at $1.32 million, down 14.3% YoY, with volume falling 17.2% to 55.33 tons. Market distribution shifted drastically amid overall export drops. Exports to Russia and Belarus totaled $1 million, taking 76.0% of all shipments versus 29.5% in H1 2025. Belarus became the top destination with export value jumping 177.5%, while the Philippines, Singapore and Indonesia’s combined share slumped from 49.3% to 11.2%.Domestically, Yunnan led exporter registrations; Jiangsu and Shanghai were key suppliers, yet Anhui and Sichuan had no exports. Heavy concentration means order or declaration changes for Russia/Belarus greatly affect national aggregate data. The data shows customs entry points (not end markets), covering tobacco consumables only, excluding heating equipment and the complete HTP supply chain.
Aug.11
2Firsts Data | China’s Vape-Related Exports Rise 16.5% in July 2026 as U.S.-Bound Shipments Jump 53.5%
2Firsts Data | China’s Vape-Related Exports Rise 16.5% in July 2026 as U.S.-Bound Shipments Jump 53.5%
China’s vape-related exports reached $1.047 billion in July 2026, up 16.5% year on year and the highest monthly total of the year. Growth was heavily concentrated in the U.S., where exports jumped 53.5% to $404 million and accounted for 94.9% of the overall increase. Exports to all other markets rose just 1.2%. By category, nicotine-containing non-combustible products—primarily vapes—under HS24041200 rose 24.7% and generated 95.5% of the total increase. Vape-device exports under HS85434000 fell 0.4%, while other nicotine-substitute products under HS24041990 grew 88.9% but remained comparatively small.
DATA
Aug.24
Nasdaq-Listed Vape Company iSpire Technology Restructures Leadership as Tuanfang Liu Becomes Sole CEO, BTIG Initiates Coverage on ODM Growth Opportunity
Nasdaq-Listed Vape Company iSpire Technology Restructures Leadership as Tuanfang Liu Becomes Sole CEO, BTIG Initiates Coverage on ODM Growth Opportunity
Nasdaq-listed vape company iSpire Technology has restructured its leadership team, with Tuanfang Liu becoming the company’s sole chief executive officer (CEO) and Michael Wang appointed CEO of Aspire North America. The move ends iSpire’s previous co-CEO structure and creates clearer responsibilities between group strategy and regional execution. Separately, BTIG initiated coverage on iSpire Technology with a Buy rating and a $3.50 price target, identifying ODM growth opportunities as a key investment factor.
Jul.27
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
A commentary published in the international open-access, peer-reviewed Harm Reduction Journal argues that randomized controlled trials remain central to evaluating smoking cessation efficacy but cannot alone capture real-world uptake, complete switching, longer-term use and population impact of non-combustible nicotine products such as e-cigarettes, heated tobacco and nicotine pouches. The authors frame impact as “reach × efficacy” and call for real-world evidence to complement RCTs. Three days after publication, the FDA authorized three JUUL2 products and highlighted complete switching among adult smokers in explaining its decision, providing a timely regulatory backdrop to the debate.
Sep.08